CompoAtlas

TestoLibre

Food supplement declared in France, declaration No 2024-2-739, decision dated 13 February 2024

TestoLibre (Wellmark) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 2 rules of use apply to its ingredients (limits and warnings).

Brand
Wellmark
Food business operator placing the product on the market
Wellmark Sarl
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 à 4 gélules
Directions for use
Prendre 2 à 4 gélules par jour pendant les principaux repas
Intended populations
Homme
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Sous antidiabétiques, Sous traitement antihypertenseur
Objectives stated by the manufacturer (these are not authorised claims)
Tonus sexuel, Sport, Système urinaire

Declaration 139068, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Trigonella foenum-graecum L.GraineExtrait sec hydroalcoolique600 mg
Tribulus terrestris L.FruitExtrait sec hydroalcoolique600 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Bisglycinate de zincZinc25 mg15 mg

Other ingredients

Gélule végétale

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

L'emploi chez les femmes enceintes et allaitantes ou en cas de traitement anti-hypertenseur ou antidiabétique est déconseillé. Réservé aux adultes.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Wellmark

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line